Clinical Cancer Epidemiology Group

Professor Amy Berrington’s group is investigating the late-effects of cancer treatments, medical radiation exposures and other medications to improve outcomes for patients.


Professor Amy Berrington

Group Leader:

Clinical Cancer Epidemiology Headshot of Amy Berrington

Professor Amy Berrington is an expert in the use of real world data to study the late-effects of cancer treatments, medical radiation exposures and other medications and is leading major studies in this field in breast and childhood cancer survivors. She is a member of multiple national and international advisory boards and is currently Vice-Chair of the US National Academy of Science Nuclear and Radiation Studies Board.

Researchers in this group

Headshot of Martina Brayley .

Email: [email protected]

Location: Sutton

Martina joined The Generations Study research team in 2023 with Professor Berrington. She came from the Department of Health and Social Care, where she worked as a Senior Public Health Intelligence Analyst monitoring the health of the population in England. She has also worked as a Nutrition Scientist in Public Health England, evaluating evidence that supported policy development and public health interventions. She has a background in Nutrition Science and completed an MSc in Epidemiology at the London School of Hygiene and Tropical Medicine in 2020, specialising in lifestyle and environmental risk factors and chronic diseases.

Headshot of Isobel Jackson .

Isobel is a PhD student within the Cancer Epidemiology and Prevention Research Unit (CEPRU), a joint initiative between Imperial College London and the Institute of Cancer Research. Her research is primarily based within the Department of Epidemiology and Biostatistics at Imperial College, supervised by Professor Marc Gunter, Professor Amy Berrington and Dr. Alicia Heath. Isobel’s PhD is focused on temporal changes in modifiable breast cancer risk factors and their association with breast cancer risk in the Generations Study. She previously gained her undergraduate degree in Biological Sciences at the University of Leeds in 2021, with a year-long internship as the Data and Information Intern at Yorkshire Cancer Research. She then received her Master of Public Health (MPH) from Imperial in 2022.

Dr Michael Jones .

Phone: +44 20 8722 4254

Email: [email protected]

Also on: michael-jones-0640a550

Location: Sutton

Dr Michael Jones is a senior staff scientist in the Division of Genetics and Epidemiology, where he is working on the Breast Cancer Now Generations Study. His main research interests are in the design and analysis of complex large epidemiological studies.

.

Email: [email protected]

Location: Sutton

Esmé joined The Generations Study research team in 2024 with Professor Amy Berrington. She came from HEOR, where she worked as a Data Scientist conducting statistical analyses to evaluate the effectiveness, safety and public health impact of new health technologies across a range of disease areas. She completed an MSc in Public Health at the University of Bristol, specialising in the mixed-methods evaluation of trauma-informed approaches to health systems. Esmé’s research focuses on exploring the relationship between pre- and post-diagnosis lifestyle factors and ovarian cancer survival.

.

Phone: +44 20 3437 6180

Email: [email protected]

Location: Sutton

Headshot of Imogen Sawyer .

Phone: +44 20 3437 6154

Email: [email protected]

Location: Sutton

Imogen joined the Generations Study research team in 2023, shortly after completing her master’s degree in Population Health Sciences from the University of Cambridge. With her background in epidemiology and data analysis, she is now working towards a PhD with Professor Berrington that investigates the late effects of breast cancer treatments. Imogen is dedicated to advancing our understanding of cancer survivorship and improving patient outcomes.

Headshot of Dawn Thomas .

Phone: +44 20 8722 4477

Email: [email protected]

Location: Sutton

Dawn joined The Generations Study research team in 2004 with previous expertise in office management, recruitment, and communications. She joined to assist managing the study launch and overseeing the recruitment and enrolment of over 100,000 women in the Generations Study. Since then, Dawn has headed the retention of study participants, contributed to managing other research projects within the team, and has assisted with staff training. Currently, Dawn provides administrative support to the senior study scientists and the research team as well as co-ordinating the Study communications and overseeing participant engagement.

Headshot of Jacqueline Wybrow Smith .

Phone: +44 20 3437 6943

Email: [email protected]

Location: Sutton

Jacqueline joined The Generations Study research team in 2022. Prior to joining the study, she has 14 years of experience working in the NHS in acute hospital, education, and primary care settings, both clinically and operationally, and 19 years in technology-based industries, including as a business analyst. At the Generations Study, Jacqueline manages the scientific research operations, helping the Principal Investigators to prioritize scientific tasks, manage budgets, oversee procurement, contracts, grant submissions, and reporting requirements. She is also responsible for the mammography collections project.

Professor Amy Berrington's group have written 472 publications

Most recent new publication 12/2024

See all their publications

Closed: Modifiable lifestyle factors and breast cancer survival and recurrence

Primary site: Sutton Funded by Breast Cancer Now Closed: Modifiable lifestyle factors and breast cancer survival and recurrence

Recent discoveries from this group

11/12/23

A woman walks her dog along a path in autumn. Trees line the path.

Image: a woman walks her dog.

Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now.

The research, published today (Monday 11 December) in the Journal of Clinical Oncology, analysed data from 19 studies from around the world, including the Breast Cancer Now Generations Study. It looked at levels of physical activity and cancer diagnoses amongst 547,000 women who had not gone through menopause.

The women were followed up for an average of 11.5 years, during which time 10,231 were diagnosed with breast cancer before menopause.

More time moving lowers the risk of breast cancer

Researchers at The Institute of Cancer Research, London, ranked the data by the amount of physical activity women reported they did during their leisure time, such as sports, cycling and recreational walking.

The results showed that the most physically active women, those in the top 10% of physical activity levels, were 10% less likely to develop breast cancer before menopause, compared to the least physically active women, defined as those in the bottom 10% of physical activity levels.

Their analysis took into account other breast cancer risk factors and lifestyle behaviours, such as BMI, family history of breast cancer, smoking and alcohol consumption.

The researchers found that there was no specific amount of physical activity that women needed to complete to see benefits, but that the more time they spent doing moderate and vigorous movement outside of work-related physical activity, the lower their risk of breast cancer.

How physical activity lowers breast cancer risk is not fully understood. Previous research suggests that physical activity can lower sex hormones like oestrogen and testosterone, which have previously been linked to increased breast cancer risk.

Physical activity lowers insulin levels and levels of growth hormones that might encourage breast cancer to grow. It also decreases general inflammation which has been associated with cancer development and progression.

'Solid evidence'

Dr Michael Jones, Senior Staff Scientist at The Institute of Cancer Research, London, said: "This new research provides us with solid evidence that greater leisure time physical activity is associated with lower risk of breast cancer in younger women. It's important to remember that breast cancer risk is influenced by several factors – including genetics, lifestyle and environment, and many of these are out of our control.

“Our research adds to the evidence that engagement in higher levels of leisure-time physical activity may lead to reduced premenopausal breast cancer risk. We still need to better understand the biology behind the link between physical activity and reduced breast cancer risk, but these findings add to the strong body of evidence showing that being physically active is good for our health."

Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said: “Although breast cancer is more common in older women, 5,000 women aged 45 or younger are given the devastating news that they have breast cancer each year in the UK. Breast cancers in younger women tend to be more aggressive and diagnosed at a later stage, so we urgently need to find new ways to prevent people from developing the disease.

“While we can’t predict who will get breast cancer, there are some things people can do to lower their risk of getting it. This research highlights how vital it is that we support women to start making small, healthy lifestyle changes that can positively impact their health and help lower their risk of breast cancer."

Breast Cancer Now is the research and support charity here for anyone affected by breast cancer. Their Younger Women Together services offer tailored support and the chance to share experiences with other younger women with breast cancer. Call their free helpline on 0808 800 6000 to speak to their expert nurses or find out more at breastcancernow.org.

This research was conducted as part of the Premenopausal Breast Cancer Collaborative Group formed under the auspices of the U.S. National Cancer Institute’s Cohort Consortium. The Premenopausal Breast Cancer Collaborative Group is funded, in part, by the Intramural Research Program of the National Institute of Environmental Health Sciences, a component of the U.S. National Institutes of Health, as well as the Institute of Cancer Research, UK.